The Staphylococcus aureus Network Adaptive Platform (SNAP) trial is an International
Multi-Centered Randomised Adaptive Platform Clinical Trial to evaluate a range of
interventions to reduce mortality for patients with Staphylococcus Aureus bacteraemia (SAB).
Phase:
Phase 4
Details
Lead Sponsor:
University of Melbourne
Collaborators:
Berry Consultants Menzies School of Health Research Queensland University of Technology Sunnybrook Health Sciences Centre Tan Tock Seng Hospital Telethon Kids Institute The Peter Doherty Institute for Infection and Immunity The University of Queensland
Treatments:
Anti-Bacterial Agents Cefazolin Clindamycin Daptomycin Lincomycin Penicillin G Penicillins Vancomycin